Quick Answer
BIOLIFE SOLUTIONS INC reported R&D Expense of $7.57 million for fiscal year 2025.
BIOLIFE SOLUTIONS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $7.57M | +59.3% |
| 2024 | $4.75M | -13.9% |
| 2023 | $5.51M | -36.4% |
| 2022 | $8.67M | -26.6% |
| 2021 | $11.82M | +75.9% |
| 2020 | $6.72M | +112.1% |
| 2019 | $3.17M | +144.1% |
| 2018 | $1.30M | +8.8% |
| 2017 | $1.19M | -41.2% |
| 2016 | $2.03M | +47.1% |
| 2015 | $1.38M | +58.3% |
| 2014 | $871.1K | +78.6% |
| 2013 | $487.8K | +5.2% |
| 2012 | $463.6K | -10.2% |
| 2011 | $516.5K | +62.0% |
| 2010 | $318.9K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.71M | +43.1% | -0.4% |
| June 30, 2025 | $2.72M | +34.0% | +23.4% |
| March 31, 2025 | $2.20M | +6.2% | +16.4% |
| September 30, 2024 | $1.89M | -49.4% | -6.7% |
| June 30, 2024 | $2.03M | -46.5% | -2.2% |
| March 31, 2024 | $2.08M | -50.0% | -44.5% |
| September 30, 2023 | $3.74M | +9.2% | -1.4% |
| June 30, 2023 | $3.79M | +10.6% | -8.6% |
- BIOLIFE SOLUTIONS INC showed an increase of +59.3% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, BIOLIFE SOLUTIONS INC’s r&d expense has grown by 2272.6% (from $318.9 thousand to $7.57 million).
- The most recent figure is from BIOLIFE SOLUTIONS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: